LifeStance Health Group, Inc.
LFSTNasdaqCIK 1845257HealthcareFiscal year ends Dec 31
Reports and events: 75 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1621:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-424294 |
| 2026-09-1120:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389315 |
| 2026-08-0620:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338107 |
| 2026-08-0600:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336057 |
| 2026-07-0720:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-297525 |
| 2026-06-0420:46 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257606 |
| 2026-05-1220:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-219669 |
| 2026-05-0720:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211814 |
| 2026-05-0723:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-209709 |
| 2026-04-2221:08 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001193125-26-170798 |
| 2026-03-1121:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-102436 |
| 2026-03-0221:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-085507 |
| 2026-02-2521:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071462 |
| 2026-02-2500:18 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-067858 |
| 2025-11-0621:29 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269712 |
| 2025-11-0623:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-267443 |
| 2025-08-2220:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-186460 |
| 2025-08-0720:29 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105096 |
| 2025-08-0723:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-104363 |
| 2025-06-0611:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-136309 |
| 2025-05-1413:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-119479 |
| 2025-05-0720:42 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065806 |
| 2025-05-0722:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064745 |
| 2025-04-2320:50 ET | DEF 14A | Proxy statementPeriod 2025-06-03 | 0000950170-25-057496 |
| 2025-02-2721:26 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029100 |
| 2025-02-2711:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-037533 |
| 2025-02-2723:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-028099 |
| 2024-12-1921:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001193125-24-282043 |
| 2024-11-0721:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123376 |
| 2024-11-0723:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122575 |
| 2024-08-0820:35 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094105 |
| 2024-08-0822:42 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-093114 |
| 2024-07-0320:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-175071 |
| 2024-06-0420:27 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-154291 |
| 2024-05-2413:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-146587 |
| 2024-05-0920:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056989 |
| 2024-05-0923:26 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-056089 |
| 2024-04-2320:25 ET | DEF 14A | Proxy statementPeriod 2024-06-03 | 0000950170-24-046929 |
| 2024-03-1213:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-029684 |
| 2024-02-2821:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022131 |
| 2024-02-2823:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-021511 |
| 2024-02-0211:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001193125-24-022199 |
| 2023-11-0821:12 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061118 |
| 2023-11-0823:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-060505 |
| 2023-08-0920:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040649 |
| 2023-08-0922:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-040033 |
| 2023-06-0210:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-159318 |
| 2023-05-1020:17 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020544 |
| 2023-05-1022:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-019901 |
| 2023-04-2120:18 ET | DEF 14A | Proxy statementPeriod 2023-06-01 | 0000950170-23-013853 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.